Log In
BCIQ
Print this Print this
 

subcutaneous hdm-ASIT+

  Manage Alerts
Collapse Summary General Information
Company ASIT biotech S.A.
DescriptionNatural peptide fragment mixture obtained from the purified specific allergen extracted from Dermatophagoides pteronyssinus bodies
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAllergy
Indication DetailsTreat house dust mite allergic rhinitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today